Associated Papers
Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2, and HBB associated with haemoglobinopathies.
Tamana S et al.
Elife, 2022
36453528 (PubMed )
Supplement: elife-79713-supp2.xlsx › Input-Full_dataset
Clinical and genetic characteristics of hemoglobin H disease in Iran.
Abolghasemi H et al.
Pediatric Hematology and Oncology, 2022
Molecular Genetic Analysis of α-Thalassemia in Hamadan Province, West Iran.
Moradi K et al.
Hemoglobin, 2020
Iranian patients with hemoglobin H disease: genotype-phenotype correlation.
Paridar M et al.
Molecular Biology Reports, 2019
The Spectrum of α-Thalassemia Mutations in the Lak Population of Iran.
Moradi K et al.
Hemoglobin, 2019
Genetics of Iranian Alpha-Thalassemia Patients: A Comprehensive Original Study.
Keikhaei B et al.
Biochemical Genetics, 2018
Molecular basis of α-thalassemia.
Farashi S et al.
Blood Cells, Molecules & Diseases, 2018
Evaluation of α-Globin Gene Mutations Among Different Ethnic Groups in Khuzestan Province, Southwest Iran.
Khosravi A et al.
Hemoglobin, 2016
Hb Souli, a 6 bp in-frame deletion on the HBA2 gene (HBA2: c.[41-46delCCTGGG]) leads to α-thalassemia intermedia, when in trans to a single α-globin gene deletion.
Kattamis A et al.
Hemoglobin, 2015
The spectrum of α-thalassemia mutations in the Kurdish population of Northeastern Iraq.
Al-Allawi NA et al.
Hemoglobin, 2013
Novel mutations responsible for α-thalassemia in Iranian families.
Bayat N et al.
Hemoglobin, 2013
Genotype-phenotype correlation in Iranian patients with Hb H disease.
Ebrahimkhani S et al.
Hemoglobin, 2011
Select a paper to view details